In Bowman v. Monsanto Co., 569 U.S. 278 (2013), the Supreme Court unanimously held that the patent exhaustion doctrine does not let a farmer reproduce patented seeds by planting and harvesting them without the patent holder’s permission. Justice Elena Kagan wrote the opinion for a 9–0 Court, drawing a hard line between using a patented item you bought and making new copies of it. Seeds naturally self-replicate when planted, and the case forced the Court to decide whether that biological fact gave buyers a free pass around patent law. It didn’t.1Library of Congress. 569 U.S. 278 – Bowman v. Monsanto Co.
The Seeds and the License Farmers Signed
Monsanto developed soybeans containing a genetic trait called Roundup Ready, which lets the plants survive glyphosate-based herbicides. Farmers can spray a field to kill weeds without harming the crop. Monsanto protected the trait with utility patents and sold the seeds only under a Technology Stewardship Agreement.
The contract allowed planting for one growing season. Farmers could not save harvested grain to replant the next year, and they could not supply seeds to anyone else for planting.1Library of Congress. 569 U.S. 278 – Bowman v. Monsanto Co. Most farmers complied by selling their harvest as commodity grain to grain elevators, which routed it to feed and processing markets rather than back into the ground.
What Vernon Bowman Did
Vernon Hugh Bowman, an Indiana farmer, followed the license for his main spring planting. For a riskier late-season second crop, he wanted cheaper seed. Instead of buying Roundup Ready seeds from a licensed dealer, he bought commodity soybeans from a local grain elevator, the kind of grain normally destined for feed or processing.
He suspected most of that commodity mix would carry the Roundup Ready trait, because most local farmers grew it. He planted the grain, sprayed with Roundup, and the surviving plants confirmed his hunch. He then saved seed from each harvest and repeated the cycle for eight growing seasons.2Justia. Bowman v. Monsanto Co.
When Monsanto discovered the practice, it sued for patent infringement under the Patent Act, which gives patent holders the exclusive right to make, use, offer for sale, or sell their invention.3Office of the Law Revision Counsel. 35 USC 271 – Infringement of Patent The district court sided with Monsanto and awarded $84,456 in damages.1Library of Congress. 569 U.S. 278 – Bowman v. Monsanto Co.
The Patent Exhaustion Argument Bowman Made
Bowman’s defense rested on patent exhaustion, a long-standing doctrine that an authorized sale of a patented item ends the patent holder’s rights over that particular item. The buyer can then use, resell, or discard it. The Supreme Court had reaffirmed the principle in Quanta Computer, Inc. v. LG Electronics, Inc.4Justia. Quanta Computer Inc. v. LG Electronics Inc.
Bowman’s chain of reasoning: local farmers grew Roundup Ready soybeans and sold the harvest to a grain elevator with Monsanto’s authorization. The elevator then sold commodity grain to him. Because the sales were authorized, exhaustion meant Monsanto could no longer dictate what he did with the physical beans, planting included. His lawyers framed the seeds’ ability to grow into new plants as a natural biological property, not manufacturing by Bowman.
Why the Court Rejected It
The Court held that “patent exhaustion does not permit a farmer to reproduce patented seeds through planting and harvesting without the patent holder’s permission.”1Library of Congress. 569 U.S. 278 – Bowman v. Monsanto Co. Exhaustion gives the buyer the right to use or resell the specific item purchased. It does not grant a license to make new copies.
When Bowman planted the commodity seeds, the Court said, he did not merely use them. He created new seeds carrying the patented Roundup Ready trait. Each new generation was a fresh article of the patented invention, and making it without authorization was infringement.2Justia. Bowman v. Monsanto Co.
Justice Kagan noted that accepting Bowman’s theory would gut patent protection for any self-replicating technology, because a single authorized sale would let one buyer supply the world.
Use Versus Reproduction
The distinction between using a patented product and reproducing it sits at the heart of the case. Buy a patented wrench, and you can tighten every bolt you own. Build a duplicate wrench in your garage, and the patent holder’s rights over new copies were never exhausted by your purchase. Seeds complicate the picture because planting is the most obvious “use,” yet planting inherently produces copies.
The Court resolved the tension by treating planting-to-harvest as production, not consumption. Bowman could have fed the commodity soybeans to livestock or sold them to a processor. That would have been permissible use of an exhausted product. Cultivating them into a new crop was manufacturing, and no prior sale authorized it.1Library of Congress. 569 U.S. 278 – Bowman v. Monsanto Co. The framework applies regardless of whether the seeds came from Monsanto, a licensed dealer, or a grain elevator. What matters is what the buyer does with them.
How the Damages Were Calculated
The district court’s $84,456 award was based on the technology fees Bowman avoided by buying commodity grain instead of licensed seed. Federal law requires patent infringement damages “adequate to compensate for the infringement” and sets a floor of “a reasonable royalty” for the infringer’s use of the invention.5Office of the Law Revision Counsel. 35 USC 284 – Damages
In seed cases, the reasonable royalty typically matches the licensing fee a farmer would have paid for legitimate access. Courts can also consider lost profits when the patent holder shows it would have made the sale itself. The statute allows judges to triple the award in cases of willful infringement.5Office of the Law Revision Counsel. 35 USC 284 – Damages Bowman’s damages stayed at the base level.
What the Ruling Does Not Cover
The decision reached deliberate reproduction. It did not reach two situations farmers and lawyers often ask about.
Inadvertent Contamination
Wind, birds, and shared equipment can carry patented seeds or pollen onto land where they were never planted. That question was addressed in Organic Seed Growers and Trade Association v. Monsanto Co., where the Federal Circuit noted Monsanto’s public commitment not to exercise patent rights where trace amounts of its patented seeds or traits end up in a farmer’s fields inadvertently. The court treated that commitment as binding through judicial estoppel, meaning Monsanto cannot reverse course and sue farmers whose contamination falls within the scope of those representations. The threshold for “trace amounts” is approximately one percent, consistent with standard seed certification levels. The protection covers inadvertent presence only. A farmer who discovers patented traits in a field and then knowingly harvests and replants that seed steps outside it.6Justia. Organic Seed Growers and Trade Assoc. v. Monsanto Co.
Other Self-Replicating Technologies
Justice Kagan explicitly limited the holding to the facts before the Court, writing that “in another case, the article’s self-replication might occur outside the purchaser’s control” or “might be a necessary but incidental step in using the item for another purpose.” The opinion acknowledged that self-replicating inventions are becoming more prevalent and diverse, and declined to address how patent exhaustion applies in those different circumstances.2Justia. Bowman v. Monsanto Co. The opinion even flagged a copyright analogy: the owner of a computer program can make a copy when doing so is an essential step in using the software. Whether a similar idea might apply to patented self-replicating technology was left open. Software, biological research tools, and DNA sequences remain uncharted.
How Bowman Fits With Later Exhaustion Law
Four years after Bowman, the Court revisited patent exhaustion in Impression Products, Inc. v. Lexmark International, Inc. (2017). Lexmark sold printer cartridges at a discount with contractual restrictions requiring buyers to use them once and return them. When Impression Products refurbished and resold used cartridges, Lexmark sued for infringement.
The Court ruled that an authorized sale exhausts all patent rights in the sold item, regardless of any post-sale restrictions the patent holder tries to impose, and that exhaustion applies equally to sales made outside the United States. Chief Justice Roberts, writing for the majority, said “patent exhaustion is uniform and automatic”: once the patent holder decides to sell, the patent monopoly in that item ends.7U.S. Supreme Court. Impression Products Inc. v. Lexmark International Inc.
Read together, the two cases form a coherent rule. A patent holder cannot use post-sale restrictions to police how a buyer uses or resells a purchased product; exhaustion prevents that. But a buyer cannot use the purchased product as a springboard to manufacture new copies of the patented invention. The sale exhausts rights over the item sold, never the right to make new items.
What Has Changed Since the Decision
Monsanto’s original Roundup Ready soybean patents expired between 2014 and early 2015. Generic versions of the original trait then became available for farmers to plant and save without licensing restrictions. Monsanto moved farmers to newer patented traits such as Roundup Ready 2 Xtend, keeping the same licensing model.
Gene-editing has begun to shift the landscape of seed licensing in ways the courts have not yet had to address. Monsanto’s license from the Broad Institute for agricultural use of CRISPR-Cas9 requires the company to allow farmers to save and replant seed from one season to the next. The Bowman rule remains the legal backdrop: without a specific license permitting seed saving, reproducing patented seeds through planting is infringement, regardless of how the trait was engineered.